Skip to main content
Log in

Akutbehandlung, Diagnostik und Nachsorge

Anaphylaxie — handeln Sie schnell und nachhaltig!

Anaphylaxis — how to act fast and sustainable

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Zusammenfassung

Auch wenn anaphylaktische Reaktionen in der Hausarztpraxis eher selten sind, erfordern sie ein effizientes Eingreifen. Wie Sie im Ernstfall am besten vorgehen und woran Sie nach Bewältigung der Akutsituation denken sollten, erfahren Sie in diesem Beitrag.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6

    Article  CAS  PubMed  Google Scholar 

  2. Ring J (ed). Anaphylaxis. Karger, Basel 2010

  3. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M et al Anaphylaxis: guidelines from the European academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026–45

    Article  CAS  PubMed  Google Scholar 

  4. Simons FE, Ardusso LR, Dimov V et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162:193–204

    Article  CAS  Google Scholar 

  5. Portier P, Richet C. De l’action anaphylactique de certains venins. C R Soc Biol. 1902;54:170

    Google Scholar 

  6. Bergmann KC, Ring J (eds). History of Allergy. Karger, Basel 2014

  7. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60:443–51

    Article  CAS  PubMed  Google Scholar 

  8. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, Roberts G, Worm M et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61

    Article  CAS  PubMed  Google Scholar 

  9. Sheik A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ. 2000;320: 1441

    Article  Google Scholar 

  10. Worm M, Eckermann O, Dölle s, Aberer QW, Beyer K, Hawranek T, Hompes s, Koehli A, Mahler V, Nemat K, Nioggemann B, Pfähler C, Rabe U, Reissig A, Rietschel E, Scherer K, Treudler R, Rueff F. Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland. Dtsch Ärztebl Int. 2014;111:367–75

    PubMed  PubMed Central  Google Scholar 

  11. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics and incidence of anaphylaxis in 2001 – 2010: A population-based study. J Allergy Clin Immunol. 2017;130:182–8

    Article  Google Scholar 

  12. Worm M, Edenharter G, Rueff F et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy. 2012;67:691–8

    Article  CAS  PubMed  Google Scholar 

  13. Hompes S, Dölle S, Grünhagen J, Grabenhenrich L, Worm M. Elicitors and co-factors in food-induced anaphylaxis in adults. Clin Transl Allergy. 2013;3:38–44

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ring J, Beyer K, Biedermann T, Bircher A et al. Leitlinie zu Akuttherapie und Management anaphylaktischer Reaktionen. Allergo J Int. 2014;23:96–112

    Article  PubMed  PubMed Central  Google Scholar 

  15. Weins AB, Eberlein B, Biedermann T. Diagnostics of alpha-gal syndrome: Current standards, pitfalls and perspectives. Hautarzt. 2019;70:36–43

    Article  PubMed  Google Scholar 

  16. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76–83

    Article  CAS  PubMed  Google Scholar 

  17. Kim TH, Yoon SM, Lee SY, Choi YM, Park CM, Kan HR, Choo SH. Biphasic and protracted anaphylaxis to iodinated contrast media. Eur radiol. 2018;28:1242–52

    Article  PubMed  Google Scholar 

  18. Rohacek M, Edenhofer H, Bircher A, Bingissen R. Biphasic anaphylactic reaction: occurrene and mortality. Allergy. 2014;69:791–7

    Article  CAS  PubMed  Google Scholar 

  19. Kalesnikoff J, Galli SJ. Anaphylaxis: mechanisms of mast cell activation. Chem Immunol Allergy. 2010;95:45–66

    Article  CAS  PubMed  Google Scholar 

  20. Genovese A, Rossi FW, Spadaro G, Galdiero MR, Marone G. Human cardiac mast cells in anaphylaxis. Chem Immunol Allergy. 2010;95:98–109

    Article  CAS  PubMed  Google Scholar 

  21. Pumphrey RSH, Roberts ISD. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53:273–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4: 285–90.

    Article  PubMed  Google Scholar 

  23. Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124:652–7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Willi Rl, Pfab F, Huss-Marp J, Buters JT, Zilker T, Behrendt H, Ring J, Darsow U. Contact anaphylaxis and protein contact dermatitis in a cook handling chicory leaves. Contact Dermatitis. 2009;60:226–7

    Article  CAS  PubMed  Google Scholar 

  25. Fleischer DM, Greenhawt M, Sussman G, Bégin P, Nowak-Wegrzyn A, Petroni D, Beyer K6, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assa’ad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 doi: https://doi.org/10.1001/jama.2019.1113 [Epub ahead of print].

  26. Wölbing F, Fischer J, Köberle M, Karlen J, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68:1085–92

    Article  PubMed  Google Scholar 

  27. Zink A, Ring J, Brockow K. Kofaktorgetriggerte Nahrungsmittelanaphylaxie. Allergologie. 2014;37:258–64

    Article  Google Scholar 

  28. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy. 2014;69:1582–7

    Article  CAS  PubMed  Google Scholar 

  29. Nassiri M, Babina M, Dölle S, Edenharter G, Rueff F, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. J Allergy Clin Immunol. 2015;135:491–9

    Article  CAS  PubMed  Google Scholar 

  30. Lang D. Anaphylactoid and anaphylactic reations: Hazards of beta-blockers. Drug Safety. 1995;12:299–304

    Article  CAS  PubMed  Google Scholar 

  31. Sturm GJ, Varga EM, Roberts G, Mosbech HM, Bilò MB, Akdis CA, Antolín-Amérigo D, Cichocka-Jarosz E, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Ollert M, Oude Elberink JNG, Pfaar O, Pitsios C, Pravettoni V, Ruëff F, Sin BA, Agache I, Angier E, Arasi S, Calderón MA, Fernandez-Rivas M, Halken S, Jutel M, Lau S, Pajno GB, van Ree R, Ryan D, Spranger O, Gerth van Wijk R, Dhami S, Zaman H, Sheikh A, Muraro A. EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. Allergy 2018;73:744–64

    Article  CAS  PubMed  Google Scholar 

  32. Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Scherer Hofmeier K, Köhli A, Bauer A, Christoff G, Cichocka-Jarosz E, Hawranek T, Hourihane JO’, Lange L, Mahler V, Muraro A, Papadopoulos NG, Pföhler C, Poziomkowska-Gêsicka I, Ruëff F, Spindler T, Treudler R, Fernandez-Rivas M, Dölle S. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy. 2018;73:1322–30

    Article  CAS  PubMed  Google Scholar 

  33. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–32

    Article  CAS  PubMed  Google Scholar 

  34. Scherf KA, Brockow K, Biedermann T, Koehler P, Wieser H. Wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2016;46:10–20

    Article  CAS  PubMed  Google Scholar 

  35. Morita E, Chinuki Y Takahashi H, Nabika T, Yamasaki M, Shiwahu K. Prevalence of wheat allergy in Japanese adults. Allergol Int. 2012;61:101–5

    Article  CAS  PubMed  Google Scholar 

  36. Nolan JP, Soar J, Zideman DA et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation. 2010;81:1219–76

    Article  PubMed  Google Scholar 

  37. Deutscher Rat für Wiederbelebung (Hsg). Reanimation 2015 — Leitlinie kompakt 2015:132–3

  38. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trial. BMJ 2003;327:20–7

    Google Scholar 

  39. Westfall und Westfall 2012. Adrenergic agonists and antagonists. In: Goodman Gilman’s pharmacological basis of therapeutics (Hardman JG et al eds). Mc Graw Hill, New York 2013: 277–333

    Google Scholar 

  40. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine (adrenaline) in anaphylaxis. Chem Immunology Allergy. 2010;95:201–10

    Article  Google Scholar 

  41. Ring J, Brockow K, Kugler C, Gebert N, Grando K, Götz D, Hutegger I, Lüthi H, Münch M, Spindler T, Schmid-Grendelmeier P, Gieler G. Neue Aspekte zur Allergie-Edukation: Beispiel Anaphylaxie. Allergo Journal. 2017;16:33–40

    Google Scholar 

  42. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108:871–3

    Article  CAS  PubMed  Google Scholar 

  43. Perkins GD, Olasveengen TM, Maconochie I, Soar J, Wyllie J, Greif R, Lockey A, Semeraro F, van de voorde P, Lott C, Monsieurs KG, Nolan JP, European resuscitation Council Guidelines for Resusitation: 2017 update. Resuscitation. 2018;123:43–50

    Article  PubMed  Google Scholar 

  44. Timmermann A, Böttiger BW, Byhahn C, Dörges V, Eich C, Gräsner JT, Hoffmann F, Hossfeld B, Landsleitner B, Piepho T, Noppens R, Russo SG, Wenzel V, Zwißler B, Bernhard M. AWMF Leitlinie 2019. „Prähospitales Atemwegsmanagement“

  45. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2012;130:597–606

    Article  CAS  PubMed  Google Scholar 

  46. Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2010;65:1205–11

    Article  CAS  PubMed  Google Scholar 

  47. Bresser H, Sander CH, Rakoski J. Insektenstichnotfälle in München. Allergo J. 1995;4:373–76

    Google Scholar 

  48. Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. Adrenalin in anaphylaxis treatment and self-administration: experiences from an inner city emergency department. Allergy. 2017;72:492–7

    Article  CAS  PubMed  Google Scholar 

  49. Rueff F, Przybilla B, Bilo MB et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047–54

    Article  CAS  PubMed  Google Scholar 

  50. Przybilla B, Ruef F, Walker B et al. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo Journal. 2011;20:318–39

    Article  Google Scholar 

  51. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int. 2015;24:94–105

    Article  PubMed  PubMed Central  Google Scholar 

  52. Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Rietschel R, Rueff F, Schnadt S, Szczepanski R, Worm M, Kupfer J, Gieler U, Ring J. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015;70:227–35

    Article  CAS  PubMed  Google Scholar 

  53. Zuberbier T, Asero R, Bindslev-Jensen C et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43

    Article  CAS  PubMed  Google Scholar 

  54. Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol. 2010;104:172–7

    Article  PubMed  PubMed Central  Google Scholar 

  55. Simons FE, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr auto-injectors: past their prime? J Allergy Clin Immunol. 2000;105:1025–30

    Article  CAS  PubMed  Google Scholar 

  56. Campbell RL, Bellolio MF, Motosue MS, Sunga KL, Lohse CM, Rudis MI. Autoinjectors preferred for intramuscular epinephrine in anaphylaxis and allergic reactions. West J Emerg Med. 2016;17:775–80

    Article  PubMed  PubMed Central  Google Scholar 

  57. European Medicines Agency. Better training tools recommended to support patients using adrenalin auto-injectors. 26 June 2015 EMA/ 411622/2015

  58. Ring J, Grosber M, Brockow K. Anaphylaxieerkennung, Notfallbehandlung und Management. Arzneimitteltherapie. 2016;34:112–9

    Google Scholar 

  59. Brockow et al. Versorgung von Patienten nach Anaphylaxie - Möglichkeiten und Defizite. Allergo J Int. (im Druck)

  60. McNeil C, Copeland J. Accidental digital epinephrine injection: to treat or not to treat? Can Fam Physician 2014;60:726–8

    PubMed  PubMed Central  Google Scholar 

  61. Ring J, Klimek L, Worm M. Adrenalin in der Akutbehandlung der Anaphylaxie. Dtsch Ärztebl Int. 2018;115:528–34

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johannes Ring.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Sie legen folgende potenzielle Interessenkonflikte offen:

Prof. Ring: Advisory board oder Vorträge für die Firmen Allmirall, Alk, Hal und Mylan; Prof. Brockow, Dr. Grosber, Dr. Weins: keine.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ring, J., Weins, A., Grosber, M. et al. Anaphylaxie — handeln Sie schnell und nachhaltig!. MMW - Fortschritte der Medizin 161, 54–65 (2019). https://doi.org/10.1007/s15006-019-0024-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-019-0024-8

Keywords

Navigation